CYTK vs BBIO

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 21, 2026

CYTK

65.5
AI Score
VS
BBIO Wins

BBIO

70.4
AI Score

Investment Advisor Scores

CYTK

66score
Recommendation
BUY

BBIO

70score
Recommendation
STRONG BUY

AI Analyst Insights

Detailed Metrics Comparison

Metric CYTK BBIO Winner
Forward P/E 117.6471 0 Tie
PEG Ratio -0.42 0 Tie
Revenue Growth -57.1% 120.4% BBIO
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 65.5/100 70.4/100 BBIO
Profit Margin 0.0% -97.0% CYTK
Beta 1.00 1.00 Tie
AI Recommendation BUY STRONG BUY BBIO

Relative Price Performance (Last 90 Days)

CYTK 1M: -7.0% · 3M: -23.3% BBIO 1M: -2.2% · 3M: -18.3%

Current Technical Phase

CYTK

Markdown
Sell / avoid

Price below a falling SMA50 (slope -8.4%), weak momentum, RSI 41

RSI (14): 40.9 · Price: $62.86

BBIO

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 49

RSI (14): 48.9 · Price: $67.74

Fundamentals Snapshot

Metric CYTK BBIO
Market Cap — —
Forward P/E -14.1 -301.6
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth -0.6% 1.2%
Gross Margin -5.0% 0.9%
Operating Margin -6.3% -0.4%
EPS -7.22 -3.54
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, BBIO is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.